Baseline Demographic Characteristics of 24598 Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Slides:

Advertisements

Similar presentations

Age-Adjusted Prevalence of Diagnosed Diabetes Among U.S. Adults

Advertisements

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:

David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

Estimated Incidence of AIDS and Deaths of Adults with AIDS, January 1985-June 2000, United States The upper curve represents estimated AIDS incidence.

Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:

Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:

Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:

New 2011 SHIFT quality of life substudy Quality of life ( QoL) in heart failure: where do we stand? Therapies that have survival benefits either have a.

Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.

Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:

Dr John Cox Diabetes in Primary Care Conference Cork

CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.

All-cause mortality by treatment group

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

2017 Annual Data Report Healthy People 2020.

Copyright © 2006 American Medical Association. All rights reserved.

ELIGIBILITY: MRC/BHF Heart Protection Study

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Baseline characteristics of patients

Prevalence of statin and beta-blocker use by clinical presentation

INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.

Nat. Rev. Cardiol. doi: /nrcardio

SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.

CV Risk Management in T2DM: What Did We Learn from ADA 2016?

Selmer R, et al. Br J Clin Pharmacol 2009;67:355-62

Description of studies for pooled analyses

TACTICS-HF Trial design: Patients with acute heart failure (reduced or preserved ejection fraction) were randomized to tolvaptan 30 mg at 0, 24, and 48.

Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V

FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.

Wesley T. O’Neal et al. JACEP 2016;2:

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:

Baseline Characteristics

Potential mechanisms whereby statins may reduce the risk of stroke

Kaplan–Meier estimates of the incidence of first heart failure hospitalization during follow-up according to the statin category among patients with type.

Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.

Characteristics of elderly patients prescribed statins after acute myocardial infarction (AMI) in Quebec, Ontario and British Columbia - Part I Zheng.

Baseline Characteristics by Baseline N-BNP Level

Trial profile GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]

Trial profile GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]

Intensity of statin treatment and possible lipid lowering treatment intolerance and/or ineffectiveness issues among patients with type 2 diabetes (aged.

Connie W. Tsao et al. JCHF 2016;4:

Baseline Characteristics According to Sex

Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.

Baseline Characteristics of the Subjects*

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Baseline Characteristics

Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:

Disposition of Patients in the Atherogenic Dyslipidemia Study

Baseline characteristics of older women (NHS I), younger women (NHS II), and men (HPFS) with a history of hypertension according to thiazide use Eric N.

Baseline Characteristics by hs-CRP

MOOD-HF Trial design: Patients with chronic systolic heart failure and comorbid depression were randomized to escitalopram (n = 185) vs. placebo (n = 187).

Flow chart of search strategy

Connie W. Tsao et al. JCHF 2016;4:

Associations between type of MI and incident HF

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

Baseline characteristics of study population

Increase of physical activity over time associated with lower HF risk

Characteristics of 3415 patients admitted to hospital with

Orly Vardeny et al. JCHF 2016;4:

One-year cumulative incidence rates of adverse clinical outcomes in 9,428 outpatients with CHF stratified by diabetes status at baseline. One-year cumulative.

Multivariable analysis of hospital days and costs for children in the last year of life, by type and number of LT-CCCs. Multivariable analysis of hospital.

Cases of and deaths from prostate cancer, with associated age-standardized incidence and mortality (per men), among Canadian men aged 45 years.

Adjusted cumulative incidence of stroke, by sex and heart failure status. Adjusted cumulative incidence of stroke, by sex and heart failure status. The.

Associations of dialysis session length with mortality and hospitalizations. Associations of dialysis session length with mortality and hospitalizations.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Adjusted cumulative disability incidence by sex and heart failure status. Adjusted cumulative disability incidence by sex and heart failure status. The.

Presentation transcript:

Baseline Demographic Characteristics of 24598 Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al. JAMA. 2006;296:2105-2111

Baseline Medical Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al. JAMA. 2006;296:2105-2111

Baseline Laboratory Tests and Medication Use of Adults With Diagnosed HF and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al. JAMA. 2006;296:2105-2111

Age- and Sex-Adjusted Rates of Death From Any Cause and Hospitalization for Heart Failure by Incident Statin Exposure Alan S. Go, et al. JAMA. 2006;296:2105-2111

Multivariable Association Between Incident Statin Therapy and Risk of Death and Hospitalization for Heart Failure Among Treatment-Eligible Patients With Heart Failure and No Previous Statin Use Alan S. Go, et al. JAMA. 2006;296:2105-2111